Drew Pantello

Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA.

Aisling Capital LLC (Aisling Capital) is an venture capital firm founded in 1999 by Dennis Joseph Purcell. The firm is headquartered in New York, New York.

Bristol-Myers Squibb Pharmaceuticals Ltd. manufactures pharmaceutical products. Its products are used for treatment of diseases like cancer, diabetes, arthritis, hepatitis, and psychiatric disorders. The company distributes products throughout the United Kingdom. Bristol-Myers Squibb Pharmaceuticals was founded in 1989 and is located in Uxbridge, UK.

Earlens Corp. develops medical devices. It offers EarLens Contact Hearing Device that uses light to transmit sound. Its earlens contact hearing device two components: a tympanic membrane transducer, which is nonsurgically placed deep in the ear canal on the eardrum, and a light-based behind-the-ear sound processor placed at the base of the ear canal. The company was founded in 1999 by Rodney C. Perkins and is headquartered in Menlo Park, CA.

Advion, Inc. engages in the development, manufacture, and support mass spectrometers, chip-based ion sources, microfluidic flow chemistry systems, and consumables for life science and related industries. Its products include expression CMS (compact mass spectrometer), Plate Express, SOLATION ICP-MS (inductively coupled plasma mass spectrometry), Triversa NanoMate, ASAP (atmospheric esolids analysis probe), and Touch Express. The company was founded by Jack D. Henion and Thomas R. Kurz in 1993 and is headquartered in Ithaca, NY.

Novazyme Pharmaceuticals, Inc. researches and develops methods for modifying recombinantly produced enzymes. It develops a series of novel protein engineering technologies that have been shown in pre-clinical studies to greatly enhance the targeting and uptake of replacement enzymes. Novazyme's technologies also have application for developing advanced monoclonal antibodies and gene therapies. The company is located in Oklahoma City, OK.

Part of International Business Machines Corp., Wilkerson Group is a consulting company that provides services to the pharmaceutical and medical products industry. The company is based in New York, NY. The company was founded by Kenneth D. Noonan. The CEO is Neil MacAllister. Wilkerson Group was acquired by International Business Machines Corp. on April 01, 1996.

Oculex Pharmaceuticals, Inc. manufactures and develops drugs. The company focuses on developing and manufacturing novel drug delivery systems that resolve the problems associated with treatment of inflammation following cataract surgery and diseases of the eye. It is located in Sunnyvale, CA.

Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark.

Medical Knowledge Group LLC engages in the provision of medical communications and health care services. It offers medical communications, health care consulting, and data analytics. The company was founded by Edward Lazarowitz, Leon Behar and Jeffrey K. Schab in 2004 and is headquartered in New York, NY.

ADMA Plasma Biologics, Inc. develops medicines for the treatment of infectious diseases. The company was founded in 2007 and is headquartered in Hackensack, NJ.

Genesis BPS LLC engages in collection, processing, storage and preparation of blood and biological fluids. Its products include GENESIS RapidWeld, TCD sterilr tube welder, blood collection monitor and data collection mixer. The company was founded by Jerrold B. Grossman and is headquartered in Ramsey, NJ.

Archimica Cooperatief UA was engaged in the manufacture of pharmaceutical products. It offered development and commercialization of pharmaceutical intermediates, active pharmaceutical ingredients, and other controlled substances. The company was headquartered in Schiphol-Rijk, the Netherlands.

ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field.

The Regenerative Medicine Foundation is a non-profit organization that aims to accelerate the development of regenerative medicine to improve health and deliver cures. The non-profit company is based in Winston-Salem, NC. The foundation fosters strategic collaborations to achieve its mission and produces its flagship event, the World Stem Cell Summit. Additionally, the foundation honors leaders in the field through the Stem Cell and Regenerative Medicine Action Awards and promotes educational initiatives.

National Hospital Specialties sells biologics, plasma, and pharmaceuticals. The private company is based in Hackensack, NJ. The company was founded by Jerrold B. Grossman, who has been the CEO since incorporation.

Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010.

Neovii Biotech GmbH develops and markets biopharmaceutical products in the field of transplantation. The company was founded in 2003 and is headquartered in Gräfelfing, Germany.